Stocks Hitting 52-Week Lows
June 28, 2016 at 11:01 AM EDT
Regulus Therapeutics Inc (NASDAQ: RGLS) shares fell 49.20 percent to touch a new 52-week low of $2.55 after the FDA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.